Food & Function · 2019 · 13 citations · 22 references
PharmacyPharmacologyPharmacotherapyCell SignalingDrug DiscoveryMolecular PharmacologyAntifibrotic TherapyEnzyme InhibitionFibrosisMarine PharmacologyNatural Product AntifibroticsPull-down AssaysPulmonary Fibrosis ProgressionSmall Molecule Antifibrotic Agents
For the first time, a new 16-amino-acid peptide was isolated from Eucheuma, an edible seaweed, and named EZY-1. EZY-1 was used to interfere with bleomycin-induced mice pulmonary fibrosis. The target proteins of EZY-1 were screened by an in vitro pull-down method combined with LC-MS/MS. The results showed that EZY-1 can inhibit the idiopathic pulmonary fibrosis (IPF) induced by bleomycin. The potency and safety of EZY-1 are superior to those of the drug used for clinical treatment, pirfenidone. The results showed that EZY-1 suppresses the TGF-β/Smad, PI3K-Akt-mTOR, Rac1-PAK2-cAb1 and MAPK signal transduction pathways. Proteins such as ERK, Akt, PDGF receptor β, vitronectin, raptor and SHP2 exhibited binding to EZY-1 in an in vitro pull-down assay combined with LC-MS/MS analysis. EZY-1 was confirmed to be an effective component of Eucheuma in the inhibition of IPF. The signalling pathways and target proteins of EZY-1 were preliminarily predicted. This study lays the foundation for the development of new drugs from Eucheuma for the treatment of IPF.
22
Ganesh Raghu, Harold R. Collard, Jim Egan et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 7.3K citations · Full text
DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide
Garry P. Nolan, Sankar Ghosh, Hsiou‐Chi Liou et al. · Cell · 1991 · 604 citations
Jonas Collén, Betina M. Porcel, Wilfrid Carré et al. · Proceedings of the National Academy of Sciences · 2013 · 383 citations · Full text
Life Sciences, Biology, Genetics +14
Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF
Paul F. Mercer, Hannah V. Woodcock, Jessica Eley et al. · Thorax · 2016 · 206 citations · Full text